NL-OMON31302已完成不适用
Treatment of Hidradenitis Suppurativa with a blue light (415 nm) and red light(633 nm) combination PDT - Hidradenitis blue-red light combination PDT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Suffering from hidradenitis suppurativa. 18-45 years old. In case of oral medication/ anticonceptives: use of at least 6 months and intention te continue use during study.
排除标准
- •-Oral medication for HS in last 2 months
- •-In menopause or postmenopausal
- •-Intention to use anticonceptives
- •-Previous external or oral use of isotretinoine in last 6 months
- •-Oral/ local anti-inflammatory medication during the last 4 weeks
- •-Pregnancy, breastfeeding, intention to conceive
- •-Photosensitivity
- •-Use of photosensitive medication
- •-treatment for cancer in the past, history of skincancer, presence of premaligne lesions
- •-Use of anticoagulants, suffering from a clotting-disease.
- •-Surgical operations in the treatment areas in the past 6 months
- •-recently had PDT for HS
- •-Recent suntanning or planning to
研究者
相似试验
已完成
2 期
Guselkumab for hidradenitis suppurativa, a mode of action study.Hidradenitis suppurativaNL-OMON48592niversitair Medisch Centrum20
进行中（未招募）
1 期
Guselkumab for the treatment of hidradenitis suppurativaHidradenitis suppurativaEUCTR2018-002978-52-NLniversitair Medisch Centrum Groningen20
已完成
不适用
Therapeutic Effect of Methalazine on 27 Cases of Suppurative HidradenitisHidradenitis SuppurativaNCT06568224The First Affiliated Hospital with Nanjing Medical University27
尚未招募
2 期
The effect of Botulinum Toxin type A in patients with axillary Suppurative HidradenitisC01.252.825.420Hidradenitis SuppurativaRBR-4sp5w6niversidade Federal de São Paulo- UNIFESP
已完成
2 期
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.Hidradenitis SuppurativaNCT03248531UCB Biopharma SRL90